March 26, 2026 · Form 4 insider transaction
Imhoff John E sold 10 shares of GUIDED THERAPEUTICS INC, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
On March 26, 2026, Mr. Imhoff converted 10 shares of Series F preferred stock into 40,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price.